Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CRGX

CARGO Therapeutics Inc

Dec 20 • 04:00PM ET

14.90

Dollar change +1.39
Percentage change 10.29	%

Healthcare • Biotechnology • USA • NASD

Peers: CRSP VRTX GILD NTLA BMRN PFE BLUE EDIT SGMO QURE

| Held by: VTI IWM VXF IWN XBI VTWO SCHA IWC VHT ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.55	Insider Own	30.34%	Shs Outstand	45.99M	Perf Week	8.44%
Market Cap	756.37M	Forward P/E	-	EPS next Y	-4.01	Insider Trans	-0.08%	Shs Float	32.06M	Perf Month	-5.82%
Income	-154.14M	PEG	-	EPS next Q	-0.96	Inst Own	81.28%	Short Float	17.63%	Perf Quarter	-23.51%
Sales	0.00M	P/S	-	EPS this Y	77.73%	Inst Trans	9.59%	Short Ratio	20.77	Perf Half Y	-4.30%
Book/sh	8.72	P/B	1.71	EPS next Y	-8.88%	ROA	-57.80%	Short Interest	5.65M	Perf Year	-19.98%
Cash/sh	7.98	P/C	1.87	EPS next 5Y	-	ROE	-69.81%	52W Range	12.17 - 33.92	Perf YTD	-35.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-35.90%	52W High	-56.07%	Beta	2.73
Dividend TTM	-	Quick Ratio	18.95	Sales past 5Y	0.00%	Gross Margin	-	52W Low	22.43%	ATR (14)	1.49
Dividend Ex-Date	-	Current Ratio	18.95	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	43.08	Volatility	13.14% 8.90%
Employees	-	Debt/Eq	0.07	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	31.38
Option/Short	Yes / Yes	LT Debt/Eq	0.07	EPS Q/Q	-2.14%	Payout	-	Rel Volume	3.80	Prev Close	13.51
Sales Surprise	-	EPS Surprise	20.62%	Sales Q/Q	-	Earnings	Nov 12 AMC	Avg Volume	272.08K	Price	14.90
SMA20	-7.85%	SMA50	-19.73%	SMA200	-22.03%	Trades		Volume	1,033,254	Change	10.29%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-26-24	Initiated	William Blair	Outperform
Jul-22-24	Initiated	H.C. Wainwright	Buy	$33
Jul-08-24	Initiated	Chardan Capital Markets	Buy	$28
Jun-27-24	Initiated	Piper Sandler	Overweight	$37
Dec-05-23	Initiated	Truist	Buy	$34
Dec-05-23	Initiated	TD Cowen	Outperform
Dec-05-23	Initiated	JP Morgan	Overweight	$23
Dec-05-23	Initiated	Jefferies	Buy	$28

Dec-17-24 08:00AM	CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-16-24 06:34PM	Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround (Zacks) +5.53%
Dec-12-24 09:55AM	Bears are Losing Control Over CARGO Therapeutics, Inc. (CRGX), Here's Why It's a 'Buy' Now (Zacks) -8.90%
Nov-12-24 04:05PM	CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) -9.98%
Nov-05-24 04:05PM	CARGO Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
09:23AM	Loading…
09:23AM	CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity (GlobeNewswire)
Aug-16-24 08:53PM	CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024 (InvestorPlace) +5.61%
06:50PM	Why Cargo Therapeutics Stock Rocketed Nearly 20% Higher This Week (Motley Fool)
Aug-12-24 04:05PM	CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire) +5.45%
Jul-10-24 08:00AM	CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet (GlobeNewswire)
Jun-04-24 04:05PM	CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director (GlobeNewswire)
01:56PM	Hedge Fund and Insider Trading News: Bill Ackman, Jim Chanos, Daniel Loeb, Mark Yusko, Citadel LLC, CARGO Therapeutics Inc (CRGX), Apple Inc. (AAPL), and More (Insider Monkey)
May-30-24 06:00AM	Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now (InvestorPlace)
May-28-24 08:05AM	CARGO Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire) -14.33%
08:00AM	CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing (GlobeNewswire)
12:00PM	Loading…
May-22-24 12:00PM	What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High? (Zacks)
May-14-24 09:54PM	CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q1 2024 (InvestorPlace) +6.55%
04:05PM	CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-15-24 04:05PM	CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors (GlobeNewswire)
Mar-21-24 10:53PM	CRGX Stock Earnings: Cargo Therapeutics Misses EPS for Q4 2023 (InvestorPlace) -6.23%
04:05PM	CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-29-24 04:01PM	CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference (GlobeNewswire)
Jan-03-24 08:05AM	CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -11.58%
Dec-18-23 04:04PM	Alexandria Snags a Pair of Big Bicoastal Lab Leases (Commercial Observer) +13.88%
Dec-13-23 10:51PM	CRGX Stock Earnings: Cargo Therapeutics Reported Results for Q3 2023 (InvestorPlace)
04:05PM	CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results (GlobeNewswire)
Dec-11-23 07:53PM	3 New Stock Listings That Can Deliver Multibagger Returns (InvestorPlace) -5.55%

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chapman Gina	President & CEO	Sep 18 '24	Option Exercise	5.03	7,166	36,045	111,071	Sep 20 05:24 PM
Chapman Gina	President & CEO	Sep 19 '24	Option Exercise	5.03	2,975	14,964	106,880	Sep 20 05:24 PM
Chapman Gina	President & CEO	Sep 18 '24	Sale	25.09	7,166	179,775	103,905	Sep 20 05:24 PM
Chapman Gina	President & CEO	Sep 19 '24	Sale	25.03	2,975	74,457	103,905	Sep 20 05:24 PM
Radhakrishnan Anup	Chief Financial Officer	Sep 18 '24	Option Exercise	5.03	1,600	8,048	8,046	Sep 20 05:23 PM
Radhakrishnan Anup	Chief Financial Officer	Sep 18 '24	Sale	25.28	1,600	40,452	6,446	Sep 20 05:23 PM
ANUP RADHAKRISHNAN	Officer	Sep 18 '24	Proposed Sale	23.33	14,000	326,620		Sep 18 04:38 PM
GINA CHAPMAN	Director	Sep 18 '24	Proposed Sale	23.33	75,000	1,749,750		Sep 18 04:36 PM
Samsara BioCapital GP, LLC	10% Owner	May 30 '24	Buy	17.00	294,000	4,998,000	4,415,689	Jun 03 09:45 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CRGX

CARGO Therapeutics Inc

Upgrade your FINVIZ experience